What is the recommended treatment for a group B strep (Streptococcus agalactiae) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2025 • View editorial policy

From the Guidelines

The recommended treatment for a Group B Streptococcus (GBS) urinary tract infection (UTI) is typically a course of antibiotics, with the specific choice depending on the patient's allergy status and other factors, as outlined in the guidelines from the CDC 1. When considering treatment options, it's essential to prioritize the most effective and safest choices. For patients without penicillin allergies, penicillin-based antibiotics are often the first line of treatment. However, the provided guideline evidence does not specify oral antibiotic regimens for GBS UTIs but focuses on intrapartum chemoprophylaxis and screening during pregnancy. Given the context of GBS UTIs, the approach should align with standard urinary tract infection treatment principles, considering the causative organism's sensitivity. GBS is sensitive to beta-lactam antibiotics, which target cell wall synthesis in gram-positive bacteria. Some key points to consider in treating GBS UTIs include:

  • The importance of completing the full course of antibiotics, even if symptoms improve before completion, to ensure the infection is fully cleared.
  • Increased fluid intake to help flush bacteria from the urinary system.
  • For pregnant women, treatment is crucial to prevent complications such as preterm labor and neonatal GBS disease.
  • Follow-up urine cultures may be recommended after treatment completion to confirm the infection has cleared. In the absence of specific oral antibiotic recommendations for GBS UTIs in the provided evidence, clinical judgment and standard treatment guidelines for UTIs caused by gram-positive organisms should guide therapy, with consideration of local resistance patterns and patient-specific factors such as allergy history. The choice of antibiotic should be guided by susceptibility patterns and patient safety, with a preference for agents effective against GBS, such as beta-lactam antibiotics, when possible 1.

From the Research

Treatment Options for Group B Strep UTI

  • The recommended treatment for a group B strep (Streptococcus agalactiae) urinary tract infection (UTI) is not explicitly stated in the provided studies, but some information can be inferred from the available data 2, 3, 4, 5, 6.
  • According to a study published in 2004, patients with GBS bacteriuria should be treated with nitrofurantoin 3.
  • Another study from 1994 recommends treating symptomatic UTI in pregnancy with amoxicillin 500 mg tid for three days, and repeating urine cultures seven days following therapy to assess cure or failure 6.
  • A review of antibiotic resistance in Group B Streptococcus found that GBS is still recognized as being universally susceptible to beta-lactam antibiotics, but there have been reports of reduced susceptibility to beta-lactams, including penicillin, in some countries 2.
  • The same review also found that resistance to second-line antibiotics, such as erythromycin and clindamycin, remains high amongst GBS, and that vancomycin is administered in instances where patients are allergic to penicillin and second-line antibiotics are ineffective 2.

Antibiotic Resistance and Treatment Duration

  • A study published in 2005 found that three-day antibiotic therapy is similar to 5-10 days in achieving symptomatic cure during uncomplicated UTI treatment, while the longer treatment is more effective in obtaining bacteriological cure 5.
  • The study also found that adverse effects were significantly more common in the 5-10 day treatment group, and that results were consistent for subgroup and sensitivity analyses 5.
  • Another study from 1997 found that group B streptococcal isolates were susceptible to teicoplanin and rifampin, but resistant to cotrimoxazole and fusidic acid, and that 69% and 51% of these isolates were susceptible to fosfomycin and rifampin, respectively 4.

Considerations for Treatment

  • When treating a group B strep UTI, it is essential to consider the antibiotic resistance patterns of the specific isolate, as well as the patient's allergy history and other health factors 2, 3, 4, 5, 6.
  • The choice of antibiotic and treatment duration should be guided by the organism's antibiotic sensitivity pattern and the patient's individual needs 3, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.